Orion Portfolio Solutions, LLC Vertex Pharmaceuticals Inc Transaction History

Orion Portfolio Solutions, LLC

$8.97 Billion
Q2 2024

A detailed history of Orion Portfolio Solutions, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Orion Portfolio Solutions, LLC holds 9,519 shares of VRTX stock, worth $4.78 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

9,519

Previous 8,386 13.51%

Holding current value

$4.78 Million

Previous $3.51 Million 27.28%

% of portfolio

0.05%

Previous 0.04%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$392.81 - $485.53 $445,053 - $550,105	1,133 Added 13.51%	9,519 $4.46 Million
Q1 2024 May 09, 2024	SELL	$407.69 - $446.08 $661,680 - $723,987	-1,623 Reduced 16.22%	8,386 $3.51 Million
Q4 2023 Feb 09, 2024	SELL	$343.0 - $410.68 $166,355 - $199,179	-485 Reduced 4.62%	10,009 $4.07 Million
Q3 2023 Nov 01, 2023	SELL	$338.18 - $362.46 $354,412 - $379,858	-1,048 Reduced 9.08%	10,494 $3.65 Million
Q2 2023 Aug 17, 2023	BUY	$314.42 - $351.91 $1.12 Million - $1.26 Million	3,571 Added 44.8%	11,542 $4.06 Million
Q2 2023 Aug 14, 2023	BUY	$314.42 - $351.91 $2.29 Million - $2.57 Million	7,292 Added 1073.93%	7,971 $2.81 Million
Q1 2023 Aug 30, 2023	SELL	$283.23 - $323.1 $187,498 - $213,892	-662 Reduced 5.74%	10,880 $3.43 Million
Q1 2023 May 15, 2023	SELL	$283.23 - $323.1 $475,259 - $542,161	-1,678 Reduced 71.19%	679 $213,000
Q4 2022 Feb 08, 2023	BUY	$285.76 - $321.48 $123,448 - $138,879	432 Added 22.44%	2,357 $680,000
Q3 2022 Nov 09, 2022	BUY	$273.83 - $305.53 $82,696 - $92,270	302 Added 18.61%	1,925 $557,000
Q2 2022 Jul 14, 2022	SELL	$234.96 - $292.55 $45,112 - $56,169	-192 Reduced 10.58%	1,623 $457,000
Q1 2022 May 19, 2022	SELL	$221.42 - $260.97 $83,918 - $98,907	-379 Reduced 17.27%	1,815 $474,000
Q4 2021 Feb 09, 2022	BUY	$177.01 - $223.45 $3,540 - $4,469	20 Added 0.92%	2,194 $482,000
Q3 2021 Nov 10, 2021	BUY	$181.39 - $202.99 $394,341 - $441,300	2,174 New	2,174 $394,000
Q2 2021 Aug 05, 2021	SELL	$187.49 - $221.1 $182,052 - $214,688	-971 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$207.02 - $241.31 $78,046 - $90,973	-377 Reduced 27.97%	971 $209,000
Q4 2020 Feb 04, 2021	SELL	$207.01 - $276.09 $34,363 - $45,830	-166 Reduced 10.96%	1,348 $319,000
Q3 2020 Nov 13, 2020	BUY	$255.65 - $303.1 $87,432 - $103,660	342 Added 29.18%	1,514 $412,000
Q2 2020 Aug 19, 2020	BUY	$225.48 - $295.8 $56,595 - $74,245	251 Added 27.25%	1,172 $340,000
Q1 2020 May 15, 2020	BUY	$199.77 - $247.81 $22,374 - $27,754	112 Added 13.84%	921 $219,000
Q4 2019 Feb 14, 2020	BUY	$166.71 - $223.91 $134,868 - $181,143	809 New	809 $177,000

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Orion Portfolio Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orion Portfolio Solutions, LLC with notifications on news.

Account

Orion Portfolio Solutions, LLC Vertex Pharmaceuticals Inc Transaction History